The risk of hospitalization with the Omicron COVID-19 variant is about one-third that of the Delta variant, according to British analysis of more than a million cases of both types in recent weeks.

Great Britain is experiencing a surge in COVID-19 cases driven by the highly-transmissible Omicron variant, with record daily infections of 189,846 reported on Friday.

While hospital admissions have started to rise, the government has said it believes the new variant is milder than the Delta variant.

The number of patients needing mechanical ventilation beds has also remained steady through December, unlike previous peaks in the pandemic.

The analysis was published by the UK Health Security Agency (UKHSA), after it worked alongside Cambridge University MRC Biostatistics unit to analyze 528,176 Omicron cases and 573,012 Delta cases.

Betty White, Hollywood icon and TV’s Golden Girl, dead at 99

“In this analysis, the risk of hospitalization is lower for Omicron cases with symptomatic or asymptomatic infection after two and three doses of vaccine, with an 81 per cent … reduction in the risk of hospitalization after three doses compared to unvaccinated Omicron cases,” the UKHSA said.

 

Susan Hopkins, Chief Medical Adviser at UKHSA, said the analysis was in keeping with other encouraging signs on Omicron, but said the health service could still struggle with such high transmission rates.

“It remains too early to draw any definitive conclusions on hospital severity, and the increased transmissibility of Omicron and the rising cases in the over 60s population in England means it remains highly likely that there will be significant pressure on the NHS in coming weeks,” she said.

Friday’s daily data update showed 12,395 patients in hospital in England with COVID-19, up from 11,542 on Thursday and continuing a steeply rising trend. However, the figure is well below a peak of more than 34,000 in January.

Omicron hospitalization risk roughly one third of Delta variant, U.K. data shows

Soundhealthandlastingwealth.com offer the most up-to-date information from top experts, new research, and health agencies, but our content is not meant to be a substitute for professional guidance. When it comes to the medication you're taking or any other health questions you have, always consult your healthcare provider directly.
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Merck to make its COVID-19 antiviral pill in Canada, company announces

Merck has reached an agreement with an Ontario pharmaceutical to make its oral COVID-19 treatment, molnupiravir, in Canada, officials said Monday.

Ontario reports record number of new COVID-19 cases with more than 16,700 infections

There are 205 people in intensive care due to COVID-19, which is an increase of five compared with Thursday.

Upwards of 80K appointments booked as Quebec opens COVID-19 vaccination for kids 5 to 11

Registrations on the Clic Santé portal began Tuesday morning for kids between the ages of five and 11 and by mid-afternoon, 80,000 appointments had been booked.

Covid Australia: Pharmacists call on ACT government to fund $10 rapid antigen tests

Covid Australia: Pharmacists call on ACT government to fund $10 rapid antigen…